Clinical utility of two-step hepatitis E virus IgM antibody testing in a low-prevalence setting: A 10-year retrospective multicenter study
A two-step HEV IgM Ab test may accurately diagnose acute HEV infection in immunocompetent persons. However, this approach fails to identify chronic HEV infection in immunocompromised individuals who need HEV RNA testing to establish the diagnosis.
Authors
- Joseph D. Yao (ORCID: https://orcid.org/0000-0002-5988-8927)
- Chia‐Yu Chiu (ORCID: https://orcid.org/0000-0002-5241-3435)
- Supavit Chesdachai (ORCID: https://orcid.org/0000-0003-3507-6411)
- Kymberly D. Watt
- Raymund R. Razonable
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1097/hc9.0000000000000611
- Primary Topic
- Hepatitis Viruses Studies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00